PETA protests against Charles River at Biotech Week Boston

By Dan Stanton contact

- Last updated on GMT

Related tags: Charles river

Campaigning group People for the Ethical Treatment of Animals (PETA) picketed a conference in Boston on Tuesday to protest the use of animals in drug research and development.

A ‘mutilated rabbit’ stood outside the Sheraton Hotel in Back Bay, Boston as part of a protest led by animal welfare group PETA against Charles River Laboratories, sponsor of the inaugural World Congress on Animal Models in Drug Discovery & Development in Boston on Tuesday.

The conference – part of Biotech Week Boston – aimed to discuss the application of traditional and non-traditional animal models, and novel in vitro​ and ex vivo​ approaches to disease modelling and drug discovery.

However, the animal welfare group claims researchers should switch to modern, non-animal based methods and accused Charles River of “using this conference to peddle its services.”

PETA chief of Laboratory Case Management Alka Chandna said: “PETA is calling on scientists at the conference to get out of the Dark Ages, admit animal studies don’t work, and commit to using in vitro testing, human organs-on-chips, and other modern research methods.”

Charles River said its work with animal-based models is both essential for discovering and developing drugs and required by the US Food and Drug Administration (FDA).

The survival rates for major diseases are at an all-time high thanks to the discovery of new drugs,” ​the contract research organization (CRO) said in a statement sent to Biopharma-Reporter. “Our work is an essential component of the research that has led to these discoveries and is required by the FDA. Charles River has played a vital role in virtually every medical advance for humans as well as animals.”

The CRO added: Charles River has a deep commitment to animal welfare and we make every effort to exceed national standards for the care of the research models under our stewardship.”

Related news

Related products

show more

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 10-Feb-2021 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 10-Feb-2021 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Rapid Biosafety Testing Enables the Future of Manufacturing

Rapid Biosafety Testing Enables the Future of Manufacturing

Viral Safety for mAb: Prevent, Detect, Remove | 23-Nov-2020 | Technical / White Paper

This white paper explores the factors driving the evolution toward faster biosafety testing and describes rapid approaches for adventitious agent testing...

Related suppliers

Follow us


View more